Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

15 Mar 2000

Abstract excerpt

Chronic myeloid leukemia (CML) is a clonal, multilineage myeloproliferative disorder characterized by the Philadelphia chromosome (Ph) and a marked expansion of myeloid cells. Previous studies have indicated that the telomere length in blood cells may indicate their replicative history. However, the large variation in telomere length between individuals complicates the use of this parameter in CML and other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Mesenchymal stem cell research
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10706851
DOI: 10.1182/blood.v95.6.1883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometryPMID 10706851Read ↗

Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell‐Associated DisordersSemantic proximity Read ↗

Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid LeukemiaSemantic proximity Read ↗

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaSemantic proximity Read ↗

Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapySemantic proximity Read ↗

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progressionSemantic proximity Read ↗

Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms.Semantic proximity Read ↗

Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemiaSemantic proximity Read ↗

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemiaSemantic proximity Read ↗

Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.Semantic proximity Read ↗

Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemiaSemantic proximity Read ↗

Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survivalSemantic proximity Read ↗

Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.